In another preclinical study, animals treated with a Dipeptidyl-peptidase IV (DPP-IV) inhibitor, which inhibits the enzyme responsible for metabolizing GLP-1, demonstrate a delayed tolerance to alcohol’s anxiolytic effects and show decreased anxiety after alcohol withdrawal (Sharma et al., 2015). Here, GLP1R is linked to Anxiety.